OptiNose
OPTN
#9290
Rank
ยฃ72.66 M
Marketcap
ยฃ7.18
Share price
0.00%
Change (1 day)
-46.28%
Change (1 year)

Revenue for OptiNose (OPTN)

Revenue in 2025 (TTM): ยฃ63.66 Million

According to OptiNose's latest financial reports the company's current revenue (TTM ) is ยฃ61.18 Million. In 2024 the company made a revenue of ยฃ62.33 Million an increase over the revenue in the year 2023 that were of ยฃ55.72 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for OptiNose from 2017 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ63.66 M2.14%
2024 ยฃ62.33 M11.87%
2023 ยฃ55.72 M-11.62%
2022 ยฃ63.04 M14%
2021 ยฃ55.3 M53.48%
2020 ยฃ36.03 M36.44%
2019 ยฃ26.4 M374.56%
2018 ยฃ5.56 M
2017 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Onconova Therapeutics
ONTX
ยฃ0.16 M-99.72%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
ยฃ0.47 B 684.38%๐Ÿ‡บ๐Ÿ‡ธ USA